Involvement of p38 MAPK in Leydig cell aging and age-related decline in testosterone
Open accessAbstract
Introduction: Age-related decline in testosterone is associated with Leydig cell aging with impaired testosterone synthesis in aging. Obesity accelerates the age-related decline in testosterone. However, the mechanisms underlying the Leydig cell aging and the effects of obesity on Leydig cell aging remain unclear. Method: Natural aging mice and diet-induced obese mice were used to assess the process of testicular Leydig cell senescence with age or obesity. Bioinformatic analysis of the young and aged human testes was used to explore key genes related Leydig cell aging. Leydig cell-specific p38 MAPK knockout (p38LCKO) mice were used to further analyze the roles of p38 MAPK in Leydig cell aging. The levels of testosterone and steroidogenic enzymes, activity of p38 MAPK, aging status of Leydig cells, and oxidative stress and inflammation of testes or Leydig cells were detected by ELISA, immunoblotting, immunofluorescence, and senescence-associated β-galactosidase (SA-β-Gal) staining analysis, respectively. Result: The serum testosterone level was significantly reduced in aged mice compared with young mice. In the testis of aged mice, the reduced mRNA and protein levels of LHCGR, SRB1, StAR, CYP11A1, and CYP17A1 and the elevated oxidative stress and inflammation were observed. KEGG analysis showed that MAPK pathway was changed in aged Leydig cells, and immunoblotting displayed that p38 MAPK was activated in aged Leydig cells. The intensity of SA-β-Gal staining on Leydig cells and the number of p21-postive Leydig cells in aged mice were more than those of young mice. Similar to aged mice, the testosterone-related indexes decreased, and the age-related indexes increased in the testicular Leydig cells of high fat diet (HFD) mice. Aged p38LCKO mice had higher levels of testosterone and steroidogenic enzymes than those of age-matched wild-type (WT) littermates, with reduced the intensity of SA-β-Gal staining and the expression of p21 protein. Conclusion: Our study suggested that obesity was an important risk factor for Leydig cell aging. p38 MAPK was involved in Leydig cell aging induced by age and obesity. The inhibition of p38 MAPK could delay Leydig cell aging and alleviate decline in testosterone.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Leydig-cell steroidogenesis is sensitive to aging, metabolic dysfunction, inflammatory stress, and changes in the testicular niche.
“Experimental and translational evidence also indicates that Leydig-cell steroidogenesis is sensitive to aging, metabolic dysfunction, inflammatory stress, and changes in the testicular niche [13,14].”
From Vitamin D Supplementation, Total Testosterone, and Androgen Bioavailability Markers in Adult Men: A Systematic Review and Meta-Analysis of Randomized Controlled Trials (2026) · cites this paper as [14]
The Results report reduced Leydig-cell steroidogenic proteins in aged and high-fat-diet mice, while the Discussion links obesity-associated oxidative stress and inflammation to Leydig-cell aging. The paper also observes changes in testicular tissue, including interstitial lipid deposition, but does not establish changes in the testicular niche as a distinct influence on steroidogenesis. Page numbers are unavailable in our copy. (LLM, conf=0.82)
Experimental — accuracy not yet measuredModern mechanistic literature on Leydig-cell aging and metabolic dysfunction supports the biological plausibility of endocrine vulnerability, but it also indicates that testosterone decline is multifactorial and unlikely to be reversed by a single micronutrient intervention in unselected populations.
“Modern mechanistic literature on Leydig-cell aging and metabolic dysfunction supports the biological plausibility of endocrine vulnerability, but it also indicates that testosterone decline is multifactorial and unlikely to be reversed by a single micronutrient intervention in unselected populations [13,14].”
From Vitamin D Supplementation, Total Testosterone, and Androgen Bioavailability Markers in Adult Men: A Systematic Review and Meta-Analysis of Randomized Controlled Trials (2026) · cites this paper as [14]
Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Adverse Events Associated with Testosterone Administration
Basaria, S., Coviello, A. D., Travison, T. G., Storer, T. W., Farwell, W. R., Jette, A. M., Eder, R., Tennstedt, S., Ulloor, J., Zhang, A., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1000485 · Cited by 1,494 · see citing works
Vigen, R. (2013) · JAMA · doi:10.1001/jama.2013.280386 · Cited by 1,003 · see citing works
Wu, F. C. W., Tajar, A., Pye, S. R., Silman, A. J., Finn, J. D., O'Neill, T. W., Bartfai, G., Casanueva, F., Forti, G., Giwercman, A., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1972 · Cited by 939 · see citing works
The central role of DNA damage in the ageing process
Schumacher, B., Pothof, J., Vijg, J., & Hoeijmakers, J. H. J. (2021) · Nature · doi:10.1038/s41586-021-03307-7 · Cited by 907 · see citing works
Increased Risk of Non-Fatal Myocardial Infarction Following Testosterone Therapy Prescription in Men
Finkle, W. D., Greenland, S., Ridgeway, G. K., Adams, J. L., Frasco, M. A., Cook, M. B., Fraumeni, J. F., & Hoover, R. N. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085805 · Cited by 735 · see citing works
Camacho, E. M., Huhtaniemi, I. T., O'Neill, T. W., Finn, J. D., Pye, S. R., Lee, D. M., Tajar, A., Bartfai, G., Boonen, S., Casanueva, F. F., et al. (2013) · European Journal of Endocrinology · doi:10.1530/eje-12-0890 · Cited by 392 · see citing works
Flagged first, then by citations
Research works printed but not linked: 49
- [1]Harman SM Metter EJ Tobin JD Pearson J. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. J Clin Endocrinol Metab (2001) 86: 724–31. doi: 10.1210/jcem.86.2.7219 11158037 · DOI · Paper page
- [2]Nieschlag E. Late-onset hypogonadism: A concept comes of age. Andrology (2020) 8: 1506–11. doi: 10.1111/andr.12719 31639279 · DOI
- [3]Kim EK Choi EJ. Compromised MAPK signaling in human diseases: An update. Arch Toxicol (2015) 89: 867–82. doi: 10.1007/s00204-015-1472-2 25690731 · DOI
- [4]Yabluchanskiy A Tsitouras PD. Is testosterone replacement therapy in older men effective and safe? Drugs Aging (2019) 36: 981–9. doi: 10.1007/s40266-019-00716-2 PMC8596965 31595418 · DOI
- [5]Dos Santos MR Bhasin S. Benefits and risks of testosterone treatment in men with age-related decline in testosterone. Annu Rev Med (2021) 72: 75– 91. doi: 10.1146/annurev-med-050219-034711 33217248 · DOI
- [6]Cole AP Hanske J Jiang W Kwon NK Lipsitz SR Kathrins M. Impact of testosterone replacement therapy on thromboembolism, heart disease and obstructive sleep apnoea in men. BJU Int (2018) 121: 811–8. doi: 10.1111/bju.14149 29383868 · DOI
- [7]Sharma R Oni OA Gupta K Chen G Sharma M Dawn B. Normalization of testosterone level is associated with reduced incidence of myocardial infarction and mortality in men. Eur Heart J (2015) 36: 2706–15. doi: 10.1093/eurheartj/ehv346 26248567 · DOI
- [8]Baillargeon J Urban RJ Kuo YF Ottenbacher KJ Raji MA Du F. Risk of myocardial infarction in older men receiving testosterone therapy. Ann Pharmacother (2014) 48: 1138–44. doi: 10.1177/1060028014539918 PMC4282628 24989174 · DOI
- [12]Etminan M Skeldon SC Goldenberg SL Carleton B Brophy JM. Testosterone therapy and risk of myocardial infarction: A pharmacoepidemiologic study. Pharmacotherapy (2015) 35: 72–8. doi: 10.1002/phar.1534 25582846 · DOI
- [13]Warburton D Hobaugh C Wang G Lin H Wang R. Testosterone replacement therapy and the risk of prostate cancer. Asian J Androl (2015) 17: 878–81. doi: 10.4103/1008-682X.150841 PMC4814970 25865848 · DOI
- [14]Cui Y Zong H Yan H Zhang Y. The effect of testosterone replacement therapy on prostate cancer: A systematic review and meta-analysis. Prostate Cancer Prostatic Dis (2014) 17: 132–43. doi: 10.1038/pcan.2013.60 24445948 · DOI
- [15]Saad F Caliber M Doros G Haider KS Haider A. Long-term treatment with testosterone undecanoate injections in men with hypogonadism alleviates erectile dysfunction and reduces risk of major adverse cardiovascular events, prostate cancer, and mortality. Aging Male (2020) 23: 81– 92. doi: 10.1080/13685538.2019.1575354 30782054 · DOI
- [16]Santella C Renoux C Yin H Yu OHY Azoulay L. Testosterone replacement therapy and the risk of prostate cancer in men with late-onset hypogonadism. Am J Epidemiol (2019) 188: 1666–73. doi: 10.1093/aje/kwz138 31145457 · DOI
- [17]Pilleron S Sarfati D Janssen-Heijnen M Vignat J Ferlay J Bray F. Global cancer incidence in older adults, 2012 and 2035: A population-based study. Int J Cancer (2019) 144: 49– 58. doi: 10.1002/ijc.31664 29978474 · DOI
- [18]Chuang YF An Y Bilgel M Wong DF Troncoso JC O'Brien RJ. Midlife adiposity predicts earlier onset of alzheimer’s dementia, neuropathology and presymptomatic cerebral amyloid accumulation. Mol Psychiatry (2016) 21: 910–5. doi: 10.1038/mp.2015.129 PMC5811225 26324099 · DOI
- [19]Koliaki C Liatis S Kokkinos A. Obesity and cardiovascular disease: Revisiting an old relationship. Metabolism (2019) 92: 98– 107. doi: 10.1016/j.metabol.2018.10.011 30399375 · DOI
- [20]Tam BT Morais JA Santosa S. Obesity and ageing: Two sides of the same coin. Obes Rev (2020) 21: 1– 21. doi: 10.1111/obr.12991 32020741 · DOI
- [21]Tajar A Forti G O’Neill TW Lee DM Silman AJ Finn JD. Characteristics of secondary, primary, and compensated hypogonadism in aging men: Evidence from the European male ageing study. J Clin Endocrinol Metab (2010) 95: 1810–8. doi: 10.1210/jc.2009-1796 20173018 · DOI · Paper page
- [22]Cao J Chen TM Hao WJ Li J Liu L Zhu BP. Correlation between sex hormone levels and obesity in the elderly male. Aging Male (2012) 15: 85–9. doi: 10.3109/13685538.2012.666585 22452321 · DOI
- [23]Mancini M Pecori Giraldi F Andreassi A Mantellassi G Salvioni M Berra CC. Obesity is strongly associated with low testosterone and reduced penis growth during development. J Clin Endocrinol Metab (2022) 106: 3151–9. doi: 10.1210/clinem/dgab535 34283215 · DOI
- [24]Kurniawan LB Adnan E Mulyono B. Insulin resistance and testosterone level in Indonesian young adult males. Rom J Intern Med (2020) 58: 93–8. doi: 10.2478/rjim-2020-0004 32134740 · DOI
- [26]Iacona R Bonomo V Di Piazza M Sansone A Usala M Novo S. Five-year prospective study on cardiovascular events, in patients with erectile dysfunction and hypotestosterone. Arch Ital di Urol e Androl (2017) 89: 313–5. doi: 10.4081/aiua.2017.4.313 29473384 · DOI
- [28]Chen H Hardy MP Huhtaniemi I Zirkin BR. Age-related decreased leydig cell testosterone production in the brown Norway rat. J Androl (1994) 15: 551–7. 7721657
- [29]Su X Lin D Luo D Sun M Wang X Ye J. Cyclophilin d participates in the inhibitory effect of high-fat diet on the expression of steroidogenic acute regulatory protein. J Cell Mol Med (2019) 23: 6859–71. doi: 10.1111/jcmm.14569 PMC6787510 31373170 · DOI
- [30]Luo L Chen H Zirkin BR. Leydig cell aging: Steroidogenic acute regulatory protein (StAR) and cholesterol side-chain cleavage enzyme. J Androl (2001) 22: 149–56. doi: 10.1002/j.1939-4640.2001.tb02165.x 11191081 · DOI
- [31]Chen H Irizarry RA Luo L Zirkin BR. Leydig cell gene expression: Effects of age and caloric restriction. Exp Gerontol (2004) 39: 31– 43. doi: 10.1016/j.exger.2003.09.021 14724062 · DOI
- [32]Kyriakis JM Avruch J. Mammalian MAPK signal transduction pathways activated by stress and inflammation: A 10-year update. Physiol Rev (2012) 92: 689– 737. doi: 10.1152/physrev.00028.2011 22535895 · DOI
- [33]Yang W Zhu L Lai S Ding Q Xu T Guo R. Cimifugin ameliorates lipotoxicity-induced hepatocyte damage and steatosis through TLR4/p38 MAPK- and SIRT1-involved pathways. Oxid Med Cell Longev (2022) 2022. doi: 10.1155/2022/4557532 PMC8958062 35355867 · DOI
- [34]He D Wu H Xiang J Ruan X Peng P Ruan Y. Gut stem cell aging is driven by mTORC1 via a p38 MAPK-p53 pathway. Nat Commun (2020) 11: 1– 13. doi: 10.1038/s41467-019-13911-x 31896747 PMC6940394 · DOI
- [35]Zhao Y Liu X Qu Y Wang L Geng D Chen W. The roles of p38 MAPK → COX2 and NF-κB → COX2 signal pathways in age-related testosterone reduction. Sci Rep (2019) 9: 1– 11. doi: 10.1038/s41598-019-46794-5 31332209 PMC6646396 · DOI
- [36]Bridges PJ Koo Y Kang DW Hudgins-Spivey S Lan ZJ Xu X. Generation of Cyp17iCre transgenic mice and their application to conditionally delete estrogen receptor alpha (Esr1) from the ovary and testis. Genesis (2008) 46: 499– 505. doi: 10.1002/dvg.20428 18781648 PMC2637183 · DOI
- [37]Engel FB Schebesta M Duong MT Lu G Ren S Madwed JB. p38 MAP kinase inhibition enables proliferation of adult mammalian cardiomyocytes. Genes Dev (2005) 19: 1175–87. doi: 10.1101/gad.1306705 PMC1132004 15870258 · DOI
- [38]López-Otín C Blasco MA Partridge L Serrano M Kroemer G. The hallmarks of aging. Cell (2013) 153: 1194–217. doi: 10.1016/j.cell.2013.05.039 PMC3836174 23746838 · DOI · Paper page
- [39]Wang Y Chen F Ye L Zirkin B Chen H. Steroidogenesis in leydig cells: Effects of aging and environmental factors. Reproduction (2017) 154: R111–22. doi: 10.1530/REP-17-0064 PMC5731485 28747539 · DOI
- [40]Cargnello M Roux PP. Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases. Microbiol Mol Biol Rev (2011) 75: 50– 83. doi: 10.1128/mmbr.00031-10 21372320 PMC3063353 · DOI · Paper page
- [41]Chen Y Wang J Chen X Li D Han X. Microcystin-leucine arginine mediates apoptosis and engulfment of leydig cell by testicular macrophages resulting in reduced serum testosterone levels. Aquat Toxicol (2018) 199: 116–26. doi: 10.1016/j.aquatox.2018.03.018 29621671 · DOI
- [42]Xiong X Zhang L Fan M Han L Wu Q Liu S. β-endorphin induction by psychological stress promotes leydig cell apoptosis through p38 MAPK pathway in Male rats. Cells (2019) 8(10): 1265. doi: 10.3390/cells8101265 31623282 PMC6829611 · DOI
- [43]Kang FC Wang SC So EC Chang MM Wong KL Cheng KS. Propofol may increase caspase and MAPK pathways, and suppress the akt pathway to induce apoptosis in MA−10 mouse leydig tumor cells. Oncol Rep (2019) 41: 3565–74. doi: 10.3892/or.2019.7129 31002349 · DOI
- [44]Liu J Chang F Li F Fu H Wang J Zhang S. Palmitate promotes autophagy and apoptosis through ROS-dependent JNK and p38 MAPK. Biochem Biophys Res Commun (2015) 463: 262–7. doi: 10.1016/j.bbrc.2015.05.042 26002468 · DOI
- [45]Xu Y Li N Xiang R Sun P. Emerging roles of the p38 MAPK and PI3K/AKT/mTOR pathways in. Trends Biochem Sci (2014) 39: 268–76. doi: 10.1016/j.tibs.2014.04.004.Emerging PMC4358807 24818748 · DOI
- [46]Wang W Pan K Chen Y Huang C Zhang X. The acetylation of transcription factor HBP1 by p300/CBP enhances p16 INK4A expression. Nucleic Acids Res (2012) 40: 981–95. doi: 10.1093/nar/gkr818 PMC3273810 21967847 · DOI
- [47]Alimbetov D Davis T Brook AJ Cox LS Faragher RG Nurgozhin T. Suppression of the senescence-associated secretory phenotype (SASP) in human fibroblasts using small molecule inhibitors of p38 MAP kinase and MK2. Biogerontology (2016) 17: 305–15. doi: 10.1007/s10522-015-9610-z PMC4819486 26400758 · DOI · Paper page
- [48]Slobodnyuk K Radic N Ivanova S Llado A Trempolec N Zorzano A. Autophagy-induced senescence is regulated by p38α signaling. Cell Death Dis (2019) 10(6): 376. doi: 10.1038/s41419-019-1607-0 31092814 PMC6520338 · DOI
- [49]Finkel T Holbrook NJ. Oxidants, oxidative stress and the biology of ageing. Nature (2000) 408: 239–47. doi: 10.1038/35041687 11089981 · DOI · Paper page
- [50]Chen H Cangello D Benson S Folmer J Zhu H Trush MA. Age-related increase in mitochondrial superoxide generation in the testosterone-producing cells of brown Norway rat testes: Relationship to reduced steroidogenic function? Exp Gerontol (2001) 36: 1361–73. doi: 10.1016/S0531-5565(01)00118-8 11602210 · DOI
- [51]Cao L Leers-Sucheta S Azhar S. Aging alters the functional expression of enzymatic and non-enzymatic anti-oxidant defense systems in testicular rat leydig cells. J Steroid Biochem Mol Biol (2004) 88: 61–7. doi: 10.1016/j.jsbmb.2003.10.007 15026084 · DOI
- [52]Ye J Luo D Xu X Sun M Su X Tian Z. Metformin improves fertility in obese males by alleviating oxidative stress-induced blood-testis barrier damage. Oxid Med Cell Longev (2019) 537: 113–27. doi: 10.1155/2019/9151067 PMC6754953 31583050 · DOI
- [53]Kim S Parks CG DeRoo LA Chen H Taylor JA Cawthon RM. Obesity and weight gain in adulthood and telomere length. Cancer Epidemiol Biomarkers Prev (2009) 18: 816–20. doi: 10.1158/1055-9965.EPI-08-0935 PMC2805851 19273484 · DOI
- [54]Horvath S Erhart W Brosch M Ammerpohl O von Schönfels W Ahrens M. Obesity accelerates epigenetic aging of human liver. Proc Natl Acad Sci U.S.A. (2014) 111: 15538–43. doi: 10.1073/pnas.1412759111 PMC4217403 25313081 · DOI
Cited by
Sorted by citations
Paez-Allendes, L., Valenzuela-Fuenzalida, J. J., Moya, M. P., Oyanedel, G., Cifuentes-Suazo, G., Figueroa-Puig, J., Orellana-Donoso, M., Mateluna-Valls, E., Cabezas-Salgado, J. J., Sanchis-Gimeno, J., et al. (2026) · Nutrients · doi:10.3390/nu18132090
- Authors
- Luo, D., Qi, X., Xu, X., Yang, L., Yu, C., & Guan, Q.
- Affiliations
- Shandong University (CN)
- Corresponding author
- Yu, Chunxiao
- Guan, Qingbo
- Venue
- Frontiers in Endocrinology
- Publisher
- Frontiers Media SA
- Published
- 2023-03-06
- Volume
- 14
- Pages
- 1088249-1088249
- ISSN
- 1664-2392 (ISSN-L)
- PMC
- PMC10025507
- OpenAlex
- W4323316741
- Cited by
- 48
- References
- 6
- Citations by year
- 2026: 18 · 2025: 17 · 2024: 12 · 2023: 1
- FWCI
- 10.72
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Endocrinology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Sperm and Testicular Function
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Physiology › Telomeres, Telomerase, and Senescence
- Keywords
- p38 MAPK, obesity, testicular steroidogenesis, steroidogenic enzymes, oxidative stress, inflammation, senescence-associated β-galactosidase, p21, high-fat diet
- MeSH terms
- Aged, Aging, Animals, Humans, Inflammation, Leydig Cells, Male, Testis, Testosterone, Cellular Senescence, p38 Mitogen-Activated Protein Kinases, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review